Vireo Growth (VREOF) Intangibles (2020 - 2026)
Vireo Growth (VREOF) posted Intangibles of $78.7 million for Q1 2026, down 30.48% sequentially from $113.2 million in Q4 2025, and up 922.81% YoY from $7.7 million in Q1 2025.
Vireo Growth (VREOF) Intangibles (2020 - 2026) Analysis & Trends
Vireo Growth has reported Intangibles for 7 years, with the latest figure at $78.7 million in Q1 2026.
- Quarterly Intangibles rose 922.81% year-over-year to $78.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $78.7 million (up 922.81% YoY) and the FY2025 annual result came in at $113.2 million, up 1332.91% from the prior year.
- Intangibles retreated to $78.7 million in Q1 2026 per VREOF's latest filing, from $113.2 million in the prior quarter.
- Over five years, Intangibles peaked at $113.2 million in Q4 2025 and troughed at $7.7 million in Q1 2025.
- A 5-year average of $27.4 million and a median of $8.8 million in 2022 frame the typical range for Intangibles.
- The sharpest annual moves came in 2023 and 2025: Intangibles fell 17.63% in 2023, then jumped 1332.91% in 2025.
- Over 5 years, Intangibles stood at $8.8 million in 2022, then slipped by 0.67% to $8.7 million in 2023, then retreated by 9.39% to $7.9 million in 2024, then surged by 1332.91% to $113.2 million in 2025, then plunged by 30.48% to $78.7 million in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $78.7 million, $113.2 million, and $83.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 3.45 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 918.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 21.28 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 13.68 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 2.23 Bn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 3.20 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 1.12 Bn |
| 10 | Vireo Growth | 487.39 Mn | 345.09 Mn | 95.30 Mn | 218.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78.70 Mn |
| Dec 31, 2025 | 113.20 Mn |
| Sep 30, 2025 | 83.18 Mn |
| Jun 30, 2025 | 79.21 Mn |
| Mar 31, 2025 | 7.69 Mn |
| Dec 31, 2024 | 7.90 Mn |
| Sep 30, 2024 | 8.10 Mn |
| Jun 30, 2024 | 8.31 Mn |
| Mar 31, 2024 | 8.51 Mn |
| Dec 31, 2023 | 8.72 Mn |
| Sep 30, 2023 | 8.94 Mn |
| Jun 30, 2023 | 8.05 Mn |
| Mar 31, 2023 | 8.62 Mn |
| Dec 31, 2022 | 8.78 Mn |
| Sep 30, 2022 | 8.94 Mn |
| Jun 30, 2022 | 9.77 Mn |
| Mar 31, 2022 | 9.94 Mn |
| Dec 31, 2021 | 10.18 Mn |
| Sep 30, 2021 | 5.42 Mn |
| Jun 30, 2021 | 3.19 Mn |